Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA: 600329)
China
· Delayed Price · Currency is CNY
27.97
-0.25 (-0.89%)
Sep 6, 2024, 3:00 PM CST
Tianjin Pharmaceutical Da Ren Tang Group Corporation Revenue
Tianjin Pharmaceutical Da Ren Tang Group Corporation had revenue of 1.98B CNY in the quarter ending June 30, 2024, with 2.51% growth. This brings the company's revenue in the last twelve months to 8.10B, down -5.42% year-over-year. In the year 2023, Tianjin Pharmaceutical Da Ren Tang Group Corporation had annual revenue of 8.22B, down -0.33%.
Revenue (ttm)
8.10B
Revenue Growth
-5.42%
P/S Ratio
2.67
Revenue / Employee
1.75M
Employees
4,619
Market Cap
18.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.22B | -26.94M | -0.33% |
Dec 31, 2022 | 8.25B | 1.34B | 19.42% |
Dec 31, 2021 | 6.91B | 303.89M | 4.60% |
Dec 31, 2020 | 6.60B | -390.23M | -5.58% |
Dec 31, 2019 | 6.99B | 635.26M | 9.99% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition